It is recommended that antiretroviral therapy be initiated with a combination of three active antiretrovirals comprised of a. A PI, a pharmacokinetic enhancer, and an INSTI b. TWO NNRTIS and a PI or INSTI c. Two NRTIS with a NNRTI, PI, or INSTI d. An integrase strand inhibitor, PI and an NNRTI